1036 results found for "":
- Home
- News & Publications
- Privacy
- Page not found
- Specific Terms & Conditions for Subscriptions
- CTRIMS & other conferences
- Contact
- 25th Annual Meeting
- PACTRIMS
- Conferences / Symposia archive
- 24th Annual Meeting
- BCTRIMS
- Other Initiatives
- Young Investigators & ECF Fellowship Community
- About the European Charcot Foundation
- Log In
- Subscription guidelines
- Search Results
- MENACTRIMS
- ECF Latin-American Symposium
- 26th Annual Meeting
- ACTRIMS 2018
- Newsletter
- Newsletter Confirmation
- EAN 2018
- Winning Poster Presentations Young Investigator Award 25th Annual Meeting
- ICTRIMS 2018
- BCTRIMS 19th Annual Meeting
- 11th PACTRIMS Congress
- Subscription MS Knowledge Hub
- Confirm your subscription
- Thank you for subscribing!
- 3rd RUCTRIMS Congress
- ECTRIMS 2018
- LACTRIMS 2018
- 4th MENACTRIMS Congress
- Actelion
- Merck
- Teva Neuroscience
- Roche
- Sanofi Genzyme
- 3rd CHARCOT LATINAMERICAN Meeting
- MS Knowledge Hub
- Welcome to the MS Knowledge Hub!
- Survey of diagnostic and treatment practices for multiple sclerosis in Europe
- Reported highlights ECTRIMS 2018: MRI / Biomarkers & Epidemiology
- Programme
- Scientific Programme
- Satellite & Industry-sponsored Symposia
- Young investigators
- Reported Highlights ECTRIMS 2018: Basic studies
- Reported Highlights ECTRIMS 2018: Treatments
- Reported Highlights ECTRIMS 2018: MRI/Biomarkers
- Reported Highlights ECTRIMS 2018: Epidemiology
- Antigen-specific treatments in MS
- MEXCTRIMS 2019
- ICTRIMS 2019
- BCTRIMS 2019
- ECTRIMS 2019
- SLCTRIMS 2019
- Chinese Medical Network of Neuroinflammation (CMNN)
- PACTRIMS 2019
- MENACTRIMS 2019
- 5th EAN Congress, Oslo 2019
- Come and see us at ECTRIMS 2019!
- BMS
- Medday
- DMD Treatment Approval for MS: 20 Years Later!
- TARGETS FOR INTERVENTIONS - The Blood-Brain Barrier in MS: a Target for Treatment?
- Pathophysiology of MS Variants: Treatment Implications
- B Cells Dependent Immune Mechanism as a Target for Intervention
- LESSONS FROM CLINICAL TRIALS - Methodology Problems: Old and New Solutions
- LESSONS FROM CLINICAL TRIALS - How to Compare Efficacy Profiles of Treatments (Meta-Analysis)
- POST MARKETING STUDIES - Methodological Aspects and Evidences
- POST MARKETING STUDIES - Safety and Tolerability
- POST MARKETING STUDIES - Adherence in MS
- IMPROVING ASSESSMENTS - Cognition and Fatigue
- IMPROVING ASSESSMENTS - Wearable Devices for Remote Control
- IMPROVING ASSESSMENTS - Patients Reported Outcomes
- TREATMENT INDIVIDUALIZATION - Personalized Medicine
- TREATMENT INDIVIDUALIZATION - MS Prognostic Aspects
- TREATMENT INDIVIDUALIZATION - Role of Omics
- TREATMENT INDIVIDUALIZATION - Role of the Organization
- MONITOR AND TREATMENT - MRI Monitoring
- MONITOR AND TREATMENT - Neurophysiology Methods
- MONITOR AND TREATMENT - Safety Monitoring
- MONITOR AND TREATMENT - Assessment of Treatment Response
- TREATMENT DECISIONS - Breaking Through Disease
- TREATMENT DECISIONS - Starting a Treatment
- TREATMENT DECISIONS - Stopping a Treatment
- TREATMENT DECISIONS - Sharing Decisions with Patients
- Effects of Treatment on Reproduction
- MS TREATMENT IN WOMEN AND CHILDREN - Treatment Decisions before and during Pregnancy
- MS TREATMENT IN WOMEN AND CHILDREN - MS Treatment during Puerperium and Lactation
- MS TREATMENT IN WOMEN AND CHILDREN - Pediatric MS
- Young Investigator: 2nd prize: Suppression of endothelin-1 expression in reactive astrocytes in vitro
- Young Investigator - 2nd prize: NEDA 3 in MS preserves from retinal axonal loss
- Young Investigator - first prize: The Role of Gut Immunity in MS Patients
- ECF Webinar: How and when to treat progressive MS - Giancarlo Comi
- XXV Opening Lecture
- Epidemiology
- Genetic
- Environmental factors
- Mucosal biopsy shows immunologic changes of the colon in patients with early MS
- Pathology
- From a T cell story to a complex immune mechanism
- Pathophysiological mechanism in the various phases of the disease
- Intrathecal inflammatory profile and cortical damage can stratify MS patients
- Diagnostic criteria a never ending story
- Classification of disease courses
- At the border of MS (NMOSD, ADEM, ANTIMOG)
- Role of brain MRI
- Role of spiral cord MRI
- Body fluids
- Neurophysiological biomarkers included OCT and more
- Clinical trial designs
- Outcome measures
- Patient reported outcomes
- Clinical trials in pediatric MS
- The evolution of treatment for relapsing MS
- Do we really hit the phenomenon of progression with available treatment?
- Efficacy and effectiveness
- Risk minimization in MS treatment
- Molecular mechanism to enhance recovery
- Where we are with physical and mental exercise
- Symptomatic treatment
- Regenerative approaches for demyelinating diseases
- How MS care is changed in Europe
- Dealing with increasing economic constraints
- Multistakeholder initiative
- MS Center organization
- Winner Young Investigator Award Julia Nedelcu: Poster Presentation
- Winner Young Investigator Award Martina Congiu: Poster Presentation
- Winner Young Investigator Award Daiana Bezzini: Poster Presentation
- Winner Young Investigator Award Marco Pisa: Poster Presentation
- Winner Young Investigator Award Bryan Ceronie: Poster Presentation
- XXVI Annual Meeting Opening Lecture
- Statistical Problems
- Methodology of extension studies
- Big data handling
- The use of multi-level modelling to produce virtual placebo groups for long-term assesment of MS drug effectiveness: experience from the risk sharing scheme
- The UCSF experience
- Clinically isolated syndrome
- The Italian MS Registry
- RelevarEM: the first MS national registry in Argentina and LATAM
- Secondary Progressive MS
- Primary Progressive MS
- Relapse and disability progression in progressive MS: the EDMUS experience
- The experience of the Swedish National Registry
- Interferons and GA
- Oral treatments
- Antibody treatments
- Natalizumab and BMT
- Anti-MOG
- NMO Spectrum disorders
- Pediatric MS
- Nationwide real world experience with pediatric onset MS
- Methodological aspects
- DMTs and infections
- DMTs and risk of cancer
- OCT
- EPS
- Brain MRI
- Spinal cord MRI
- Long-term studies of cognitive dysfunctions in MS
- Fatigue
- Depression
- DMTs and reproduction
- Opening XXVI th Annual Meeting of The European Charcot Foundation by Giancarlo Comi
- Patient reported outcomes
- How and when to treat progressive MS
- New view on MS pathology
- How to Treat MS Today
- Role of MRI to monitor disease course and response to treatment
- Understanding optic neuritis: role of functional tests and OCT
- Comorbidities in MS
- Prognosis in MS
- Are Neurofilaments a valid biomarker in MS?
- Webinar "reported highlights ECTRIMS 2018: Treatment & Basic Studies"
- MS Genetics
- Present and future of antibody treatment in MS
- Reported Highlights ECTRIMS 2019: MRI
- Reported Highlights ECTRIMS 2019: Epidemiology
- Reported Highlights ECTRIMS 2019: Treatment
- Clinical Isolated Syndromes
- Neuroprotective Strategies in progressive MS
- Treatment selection & sequencing for relapsing MS
- Multi-Stakeholder Initiatives
- MS in the 21st Century
- PROMS
- MS Data Alliance
- MS Brain Health
- Neuro-Compass
- ParadigMS
- European Multiple Sclerosis Platform
- MSIF
- Italian MS Society
- MS Care Unit
- MULTI-ACT first project results event: Does your research impact society responsibly?
- PROMS
- 28th Annual Meeting
- XXVII Annual Meeting Opening Lecture
- Session VIII: Effect of Immunomodulating Therapies on B Cells
- Session VII: How to Monitor Treatment Effects of B Cell Directed Therapies?
- Session VI: Risk Management
- Session V: B Cell Directed Therapies
- Session IV: Role of Pathogenic Antibodies. The Example of MOG Antibody Associated IDD
- Session III: Intrathecal Antibodies in MS
- Session II: B Cells in the MS CNS Compartment
- Session I: Basic Aspects of B Cells in MS
- B Cells Therapy in Pediatric Age
- Intrathecal Anti-CD20: Effect or Fiction?
- B Cell Repopulation after Anti-CD20 Treatment
- Lessons from Failures (Targets of B Cell Directed Treatments)
- Functional Measures
- MRI of Cortical Lesions
- Role of Conventional Brain and Spinal Cord MRI
- The Importance of MS Centre Organization
- Long Term Adverse Effects
- Management of Early Complications
- Preventing Risks
- Molecular Mechanisms that Modulate the Immunoprotective Response of B Cells. A Different View to our Current Approach
- Future Developments
- Treatment of Primary Progressive MS
- Treatment of Relapsing MS
- The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
- The Pathological Spectrum of MOG Antibody Associated Disease
- From Immunology to Treatment
- Epidemiology of MOG Antibody Associated Disease
- Auto-antibodies in MS
- IgG - IgM as Markers of Disease State and Courses
- Pathogenic Auto-antibodies Produced by CSF Plasma Cells
- Oligoclonal Immunoglobulins in the CSF versus CNS Lesions
- In Vivo MRI Evidence of Disruption of the Blood-meningeal Barrier
- B Cell and Cortical Demyelination
- Interaction of Glial Cells and B Cells in MS
- B Cells in MS Lesions: When, where and how many?
- ALCAM regulates B Lymphocyte Migration across Central Nervous System Barriers
- Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
- B Cell Migration into the CNS
- B Cells as Modulator of immune responses
- Reported Highlights ECTRIMS 2019: Body Fluids Biomarkers
- Reported Highlights 27th Annual Meeting: Risk Management
- Reported Highlights 27th Annual Meeting: B Cells in the MS CNS Compartment
- Reported Highlights 27th Annual Meeting: Intrathecal Antibodies in MS
- Reported Highlights 27th Annual Meeting: Role of Pathogenic Antibodies. The Example of MOG Antibody Associated IDD
- Reported Highlights 27th Annual Meeting: Basic Aspects of B Cells in MS
- Reported Highlights ECTRIMS 2019: Basic Studies
- Reported Highlights 27th Annual Meeting: How to Monitor Treatment Effects of B Cell Directed Therapies?
- Reported Highlights 27th Annual Meeting: Effect of Immunomodulating Therapies on B Cells
- Reported Highlights 27th Annual Meeting: B Cell Directed Therapies
- Reported Highlights ECTRIMS 2019: Epidemiology & Treatment
- Registration Info
- About accreditation
- Hotel Reservation
- Accreditation: Reported Highlights ECTRIMS 2019: Epidemiology & Treatment
- Presenting a poster
- Submission criteria
- Why submit an abstract?
- Scientific Programme 28th Annual Meeting
- Faculty of the 28th Annual Meeting
- EAN Virtual Congress
- BCTRIMS 2020
- ICTRIMS 2020
- MEXCTRIMS 2020
- Neurorehabilitation in MS - applied neuroplasticity
- CONy
- Pre-Course to the joint ACTRIMS/ECTRIMS virtual meeting - MSVirtual2020
- Reported Highlights ECTRIMS 2019: MRI & Body Fluids Biomarkers
- Accreditation: Reported Highlights ECTRIMS 2019: MRI & Body Fluids Biomarkers
- Scientific Programme 28th Annual Meeting - Digital Edition
- Registration and Fees
- Young Investigators
- Young Investigator Awards
- Faculty
- MSVirtual2020
- LACTRIMS 2021
- 28th Annual Meeting Scientific Committee
- Pre-Course to the joint ACTRIMS/ECTRIMS virtual meeting - MSVirtual2020
- Chinese Neurological Association, CMNN & ECF joint Symposium
- Newsletter Thank you
- SLCTRIMS 2020
- 4th RUCTRIMS Congress
- Satellite Symposia
- Accreditation Info
- 57th Argentinian Congress of Neurology
- RWE Virtual Symposium
- Understanding progressive MS
- Treatment decisions in progressive MS
- Neuroprotective treatments
- Poster Presentations
- Session Recordings
- Poster Viewing Sessions
- Poster Presentations
- Vandebergh Marijne 02
- Custódio Da Silveira Raquel 03
- García-Bermúdez Ricardo 04
- Pinto Bárbara 05
- Ng Huah Shin 06
- Koubiyr Ismail 08
- Borrelli Serena 09
- Baeva Maria-Elizabeth 11
- Matias Vieira de Melo Elisa 12
- Boshra Amir 13
- Rauma Ilkka 14
- Hänninen Katariina 16
- Arbeu-Reyes Marlene 17
- Eggebrecht Julius 20
- Eggebrecht Julius 21
- Cacciaguerra Laura 23
- Mirza Ali 25
- Langeskov-Christensen Martin 26
- Sánchez Sanz Alicia 28
- Taylor Thomas 29
- Pisa Marco 35
- Pisa Marco 36
- Cola Gaia 39
- Ramos Erasmo 42
- Elands Sophie 43
- Elands Sophie 44
- Lehikoinen Joonas 45
- Jacobs Benjamin 47
- Bonacchi Raffaello 49
- De Meo Ermelinda 50
- Guerrieri Simone 52
- Melanis Konstantinos 53
- Melnikov Mikhail 54
- Dalla Costa Gloria 56
- Melnikov Mikhail 57
- Gomez-Figueroa Enrique 58
- Bezerra de Oliveira Costa Sofia 59
- Casallas Vanegas Adriana 60
- Parks Natalie 61
- Castoldi Valerio 62
- Marenna Silvia 63
- Ozturk Onural 64
- Giordano Antonino 65
- Januel Edouard 66
- Bunul Sena Destan 69
- Podda Jessica 70
- Cunha Inês 71
- Gouiti Hind 72
- Yin Hexiang 77
- Nakajima Akihiro 84
- Matsumoto Yuki 86
- Zhang Li-Jie 87
- Zhang Li-Jie 88
- Ghasemi Maryam 95
- Andersen Oluf 15
- Selmaj Krzysztof 18
- Palte Michael 19
- Cooper Cornelia 22
- Ziemssen Tjalf 24
- Willmer Jonathan 27
- Ghezzi Angelo 30
- Montalban Xavier 31
- Montalban Xavier 32
- Wiendl Heinz 33
- Kappos Ludwig 34
- Freedman Mark S. 37
- Lair Lindsey 38
- Zierhut Matthew 40
- Labiano Andres 41
- Dive Dominique 48
- D'haeseleer Miguel 51
- Silva Berenice Anabel 67
- Zhang Yao 68
- Maghbooli Mehdi 73
- Fujimori Juichi 75
- Miyazaki Yusei 76
- Tian Decai 79
- Zhang Chao 80
- Tian Decai 81
- Habek Mario 82
- Isobe Noriko 83
- Liu Qiang 90
- Hor Jyh Yung 92
- Takai Yoshiki 93
- Niino Masaaki 94
- Young Investigator Award Winners 2020
- Satellite Symposium - Sanofi Genzyme
- Satellite Symposium - Roche
- Satellite Symposium - Novartis
- Satellite Symposium - MS in the 21st Century
- Satellite Symposium - Merck
- Satellite Symposium - Celgene BMS
- Closing & Young Investigator Award Ceremony
- Session VIII: Environment & treatment
- Session VII: Do environmental factors modulate disease evolution?
- Session VI: Other environmental factors
- Session V: Vitamin D
- Session IV: Infections
- Session III - Pollution
- Session II - Microbiota
- Session I: Updates in epidemiology
- ACTRIMS Lecture
- XXVIII Annual Meeting Opening Lecture
- Methodological bias in epidemiological studies
- Investigating the environmental risk factors: the lesson from Parkinson disease
- Geographic distribution of MS and migration studies
- Gene environment interactions in MS
- An introduction to the gut microbiota
- Microbioma and immune system
- Epidemiological studies of the gut microbiota and Multiple Sclerosis
- Human interventional studies
- Epidemiological evidences of the role of air pollution in MS
- Smoking and organic solvents in the context of MS risk genes in relation to risk of MS
- Is smoke influencing the risk of MS?
- Effects of smoke on immune system: implications for MS
- Is EBV present in the MS brain? Yes
- Is EBV present in the MS brain? No
- HERV-W role in MS
- Covid-19 and MS
- Epidemiological studies
- How vitamin D impacts on the immune system in MS
- Interventional studies
- Clinical trials of effects of vitamin D in RRMSe
- Salt
- Alcohol
- Concussion in adolescence, other causes of CNS inflammation, and subsequent MS risk
- Stress
- RIS/CIS
- Relapsing remitting and progressive MS
- Role of environmental comorbidities
- Environmental factors in Progressive MS
- Effects of environmental factors on response of DMTs
- Impact of DMTs on the risk of infection
- How to handle the risk of infections
- Can diet be considered a treatment of MS?
- ACTRIMS Forum 2021
- CONy 2021
- BCTRIMS 2021
- Accreditation Info
- Actrims Forum 2021: Silent progression: does it exist?
- Registration and Fees
- Scientific Programme 29th Annual Meeting - Digital Edition
- Mystery Solved Project
- Presenting a poster
- Submission criteria
- Why submit an abstract?
- Young Investigator Awards
- Young Investigators
- 29th Annual Meeting Scientific Committee
- MEXCTRIMS 2021
- 4th Charcot Latin-American Meeting
- Pre-ECTRIMS course
- ECTRIMS 2021
- Fellowship Programmes
- Faculty
- PACTRIMS 2021
- MENACTRIMS 2021
- EAN 2021
- XXV World Congress of Neurology
- Events
- 29th Annual Meeting: MS at the extremes
- 4th RUCTRIMS Congress
- 24th Annual Conference of Chinese Neurological Association
- Satellite Symposia Programmes
- Poster Viewing Sessions
- Poster Presentations
- Young Investigator Award Winners 2023
- Brandet João Marcos 4
- Borrelli Serena 5
- Vural Ezgi 6
- Niino Masaaki 7
- Rieckmann Peter 8
- Ng Huah Shin 9
- Arbeu-Reyes Marlene 11
- Calocer Floriane 12
- Colombo Emanuela 13
- Pisa Marco 14
- Castoldi Valerio 15
- Graf Jonas 16
- Vandebergh Marijne 17
- Schreiber Herbert 18
- ECF Live-Streamed Webinar on "Impact of Covid-19 on MS"
- Raimo Simona 19
- Rossi Elena 22
- PACTRIMS 2021
- Baradaran Saeideh 23
- Brichetto Giampaolo 24
- Eggebrecht Julius 25
- Ricigliano Vito 26
- Smith Kelsi 27
- Riemenschneider Morten 28
- Koubiyr Ismail 29
- Bar-Or Amit 30
- Casallas Vanegas Adriana 31
- Bsteh Gabriel 32
- Watson Cameron 33
- Bsteh Gabriel 34
- Scaramozza Matt 35
- Cole Michele 36
- Schreiber Herbert 37
- Brichette Isabel 38
- Marenna Silvia 39
- Kalinin Ivan 40
- Andreeva Mariia 41
- Kaplan Sigal 42
- Montalban Xavier 43
- Kuhle Jens 44
- Arnold Douglas L. 45
- Bezerra de Oliveira Costa Sofia 46
- Camera Valentina 48
- Camera Valentina 49
- Steinman Lawrence 47
- Scaramozza Matt 50
- Banwell Brenda 51
- Butz-Ostendorf Markus 52
- Beckers Lien 53
- Pisa Marco 54
- Tibar Houyam 55
- Arnold Douglas L. 56
- Selmaj Krzysztof 57
- Vermersch Patrick 58
- Spindler Tassja 59
- Boldrini Vinicius 61
- Boldrini Vinicius 62
- Dalla Costa Gloria 63
- Guerrieri Simone 64
- Yin Hexiang 65
- Pantazou Vasiliki 66
- Zhang Yao 67
- Zhang Li-Jie 68
- Melnikov Mikhail 70
- Waldman Alex 73
- Galiulin Timur 74
- Akrivaki Alexandra 75
- Sánchez Sanz Alicia 76
- Bunul Sena Destan 77
- ICTRIMS 2020
- MENACTRIMS 2021
- Accreditation: 28th Annual Meeting Session VI: OTHER ENVIRONMENTAL FACTORS
- CONy 2022: 16th World Congress on Controversies in Neurology
- CONy 2022: 16th World Congress on Controversies in Neurology
- The impact of Covid-19 on MS
- PROMS meeting
- Braune Stefan 69
- Accreditation: 29th Annual Meeting Session III: Paediatric MS
- Accreditation: 29th Annual Meeting Session VI: Anti-MOG
- Accreditation: 29th Annual Meeting Session VIII: Miscellenea/Atypical
- Session I: Radiological Isolated Syndrome
- ACTRIMS Lecture 2021
- Session II: New Diagnostic Criteria
- Session III: Paediatric MS
- Session IV: Late Onset MS
- Session V: NMOSD
- Session VI: Anti-MOG
- Session VII: Aggressive MS
- Session VIII: Miscellanea/Atypical
- Session I: Radiological Isolated Syndrome
- ACTRIMS Lecture 2021
- Session II: New Diagnostic Criteria
- Session III: Paediatric MS
- Session IV: Late Onset MS
- Session V: NMOSD
- Session VI: Anti-MOG
- Session VII: Aggressive MS
- Session VIII: Miscellanea/Atypical
- Satellite Symposium - Merck
- Satellite Symposium - Sanofi Genzyme
- Satellite Symposium - Merck (MS21st Century)
- Satellite Symposium - Roche
- Satellite Symposium - BMS
- Poster Viewing Session I - Basic Studies
- Poster Viewing Session II - Clinical
- Poster Viewing Session III - Epidemiology
- Poster Viewing Session IV - Investigations & Treatment
- Young Investigator Awards & Concluding Remarks
- Poster Viewing Session I - Basic Studies
- Satellite Symposium - Merck
- Satellite Symposium - Sanofi Genzyme
- Satellite Symposium - Merck (MS21st Century)
- Satellite Symposium - Roche
- Satellite Symposium - Janssen
- Satellite Symposium - BMS
- Poster Viewing Session II - Clinical
- Poster Viewing Session III - Epidemiology
- Poster Viewing Session IV - Investigations & Treatment
- Opening XXIX Annual Meeting + Charcot Lecture
- Opening XXIX Annual Meeting + Charcot Lecture
- Definition, demographic and natural history
- Role of biomarkers
- Treating RIS? Yes
- Treating RIS? No
- Optic Nerve as Fifth Site
- Central vein sign and other MRI signs
- Neurofilaments and other body fluids
- Role of neurophysiology
- Immunological aspects
- Clinical findings
- Cognitive, emotional and affective problems
- How to treat paediatric MS
- Why so late? (immunosenescence)
- Epidemiology
- Very late onset MS and differential diagnosis
- Treat or not to treat?
- Clinical features and epidemiology
- Update on immunopathology
- Treatment strategies
- Seronegative NMOSD
- Adult disease
- Paediatric disease
- Pathophysiology
- Treatment strategies
- Defining aggressive MS
- The role of pathologist
- MRI findings
- Treatment
- Leuco-cortical and cortical forms
- Does the benign form really exists?
- The isolated endophenotypes
- Can we consider discontinuing MS DMT?
- ACTRIMS forum
- pre-ECTRIMS course
- ECTRIMS
- ECTRIMS 2022
- Pre-ECTRIMS Workshop 2022
- ACTRIMS forum
- 3rd Annual Congress of the Sri Lanka Committee for Treatment and Research in Multiple Sclerosis & Related Disorders (SLCTRIMS)
- EAN Congress 2022
- EAN Congress 2022
- 3rd Annual Congress of the Sri Lanka Committee for Treatment and Research in Multiple Sclerosis & Related Disorders (SLCTRIMS)
- Set password
- Password reset confirmation
- ECF live-streamed Webinar on "How to Optimize the Choice of Treatment"
- Scientific Programme
- Registration Information
- How to Optimize the Choice of Treatment
- Accreditation: How to Optimize the Choice of Treatment
- Hotel Reservation
- ECF live-streamed Webinar on Assessment of Treatment Response
- MEXCTRIMS 2022
- BCTRIMS 2022
- Abstract Submissions are OPEN! Present your poster!
- Submission criteria
- Why submit an abstract?
- Young Investigator Awards
- Young Investigators
- Charcot Multiple Sclerosis Master (M.Sc.)
- MENACTRIMS 2022
- Real-world evidence symposium in MS
- CNA: Chinese Neurology Association Meeting
- MEXCTRIMS 2022
- BCTRIMS Regional Nordeste 2022
- ParadigMS
- LACTRIMS 2022
- MENACTRIMS 2022
- CNA: Chinese Neurology Association Meeting
- Real-world evidence symposium in MS
- PACTRIMS 2022
- PACTRIMS 2022
- ECF Webinar 2022: Assessment of Treatment Response
- Accreditation: Assessment of Treatment Response
- MEXCTRIMS 2023
- BCTRIMS Regional Nordeste 2022
- Mystery Solved Project - Thursday, 7 July 2022
- Mystery Solved Project - Friday, 8 July 2022
- Mystery Solved Project - Tuesday, 5 July 2022
- Mystery Solved Project - Wednesday, 6 July 2022
- Accreditation Info
- 30th Annual Meeting Scientific Committee
- Sanofi 2022
- New ECF publication in the journal Brain Communications
- CLAIMS Project officially launched!
- Human Brains: Preserving the Brain. Forum on Neurodegenerative Diseases
- Satellite Symposia Programmes
- Poster Viewing Sessions
- Kessler Wiebke 5
- Schmitz-Gielsdorf Laura Eleonora 6
- Windener Farina 7
- Brandet João Marcos 16
- Caba Bastien 20
- Pisa Marco 22
- Van HIjfte Liesbeth 28
- Caba Bastien 35
- Spinat Quentin 40
- Pansieri Jonathan 46
- Okutan Betul 47
- Kee Rachael 55
- Novak Stenstad Frederik 57
- Elena Rossi 61
- Ramaglia Valeria 21
- Grigoriadis Nicolaos 29
- Häusler Darius 39
- Husseini Leila 59
- Castoldi Valerio 63
- TEST TEST 5
- Poster Presentations
- Borrelli Serena 38
- Beyer Thorben 44
- Balcerac Alexander 66
- Reich Daniel 14
- Willmer Jonathan 15
- Taranu Daniela 25
- Silva Diego 34
- Silva Diego 36
- Vermersch Patrick 37
- Weber Martin 64
- Hobart Jeremy 65
- Geladaris Anastasia 19
- Pogoda-Wesołowska Aleksandra 33
- Gaggiola Marta 42
- Gaggiola Marta 43
- Marenna Silvia 54
- Dini Michelangelo 62
- Fox Robert 12
- Willmer Jonathan 23
- Richter Joachim 27
- Meier Tanja 49
- Siegenthaler Walter 50
- Giordano Antonino 45
- Waldman Alex 51
- Cohen Mikael 3
- Cohen Mikael 4
- Brichette Mieg Isabel 24
- Huang Su-Chun 30
- Ziehn Marina 31
- Leon Castillo Daniela Alexia 17
- Leon Castillo Daniela Alexia 18
- Icometrix
- Naughton Michelle 58
- Melnikov Mikhail 56
- Giordano Antonino 45
- Bergeron - Vitez Himali 48
- Koubiyr Ismail 26
- Glanzman Robert 13
- Willekens Barbara 60
- Scientific Programme
- Satellite Symposia Programmes
- Poster Viewing Sessions
- Poster Presentations
- Registration Information
- Hotel Reservation
- Young Investigators and ECF Fellows presenting a poster
- Abstract Submissions are OPEN! Present your poster!
- Submission criteria
- Why submit an abstract?
- Young Investigator Awards
- Accreditation Info
- 31st Annual Meeting Scientific Committee
- Cookie Policy
- Young Investigator Award Winners 2021
- Samadzadeh Sara 08
- 30th Annual Meeting Opening & ECF Lecture
- Satellite Symposium - Bristol Myers Squibb
- Session III - Contribution of epidemiology to understanding progression
- Session IV - Biomarkers
- Session V - Clinical trials designs and outcomes
- Session VI - Treatment of PMS today
- Announcement Young Investigator Award Winners
- Session VII - Future Treatments: possible targets
- Actrims Lecture
- Young Investigator Awards
- Session VIII - Raising the bar to stop progression: a global approach
- Concluding Remarks
- SLCTRIMS 2023
- ACTRIMS 2023
- Session II - Mechanistic aspects
- Patient-Reported Outcomes for MS (PROMS) Plenary Event 2022
- MS Data Alliance Stakeholder Engagement Meeting 2022
- ECF Small Grant
- CONy 2023: The 17th World Congress on Controversies in Neurology
- ICTRIMS 2023
- BCTRIMS 2023
- 2023 JOINT Pre-ECTRIMS COURSE
- Annual BCTRIMS-ECF Joint Meeting
- ACTRIMS Forum 2024
- MSMilan2023 - The 9th joint ECTRIMS - ACTRIMS Meeting
- Scientific Programme
- Satellite Symposia Programmes
- Poster Viewing Sessions
- Poster Presentations
- Registration Information
- Hotel Reservation
- Young Investigators and ECF Fellows presenting a poster
- Abstract Submissions are OPEN! Present your poster!
- Submission criteria
- Why submit an abstract?
- Young Investigator Awards
- Accreditation Info
- 31st Annual Meeting Scientific Committee
- Sandoz
- MENACTRIMS 2023
- LACTRIMS 2023
- EAN 2024
- Shi Kaibin 9
- Mainguy Marie 11
- Gradassi Alessandro 50
- Insight 10
- CONy 2024
- SLCTRIMS 2024
- PACTRIMS 2023
- BCTRIMS 2024
- ECTRIMS 2024
- 34th Annual Meeting, 12 - 14 November 2026: "Treatment Efficacy & Risk Management across the disease course".
- Registration Information
- Hotel Reservation
- Young Investigators and ECF Fellows presenting a poster
- Young Investigator Awards
- Accreditation Info
- 34th Annual Meeting Scientific Steering Committee
- Young Investigator Award Winners 2023
- Session I - Pathology
- Opening, XXXI ECF Lecture - Otto Hommes Opening Lecture & Session I
- Session II - Factors Influencing Recovery
- Session III & Session IV
- Session V & Session VI
- Session VII , Young Investigators Awards, Session VIII & Concluding Remarks
- MEXCTRIMS 2024
- Satellite Symposium - Sanofi
- Satellite Symposium - Merck
- Satellite Symposium - Roche
- Announcement Young Investigator Award Winners & ACTRIMS
- PROMS
- Privacy Notice and Terms & Conditions
- #ECF2026 - LinkedIn & X promotional tools
- MENACTRIMS 2024
- ICTRIMS 2024
- PACTRIMS 2024
- WNU 2024: World Federation of Neurology Digital Neurology Updates
- Annual BCTRIMS-ECF Joint Meeting
- Annual BCTRIMS-ECF Joint Meeting 2024
- 'Update on NMOSD and MOGAD' Workshop
- Erhart Deborah 31
- Rival Manon 33
- Rossi Elena 38
- Boschetti Angela 40
- Dini Michelangelo 43
- Tacchini Marta 48
- Boi Anna 65
- Qi Zhihui 69
- Camera Valentina 73
- Samadzadeh Sara 77
- Pimentel Vitória 78
- Stanikic Mina 79
- Tseriotis Vasilis-Spyridon 87
- Anderhalten Lina 91
- Deftereos Spyros 16
- Sormani Maria Pia 41
- Ricigliano Vito 44
- Tunç Abdulkadir 49
- Vermersch Patrick 50
- Seferoğlu Meral 56
- Vermersch Patrick 61
- Vermersch Patrick 63
- Vermersch Patrick 64
- Vermersch Patrick 67
- Gradassi Alessandro 81
- Natek Maja 99
- Balz Luisa Theresa 5
- Alemani Rebecca 10
- Xiao Zichun 15
- Marenna Silvia 29
- Scheinok Thomas 30
- Guan Haonan 36
- Li Yu-Jing 37
- Chang Yingying 54
- Lockhart Andrew 57
- Cheng Nuo 59
- Pisa Marco 62
- Pisa Marco 66
- Pansieri Jonathan 18
- Melnikov Mikhail 20
- Kieseier Bernd 42
- Illes Zsolt 52
- Castoldi Valerio 92
- Orozco Patricia 4
- Plesa Andreea 6
- Smith Kristina 12
- Gavoille Antoine 23
- Gavoille Antoine 24
- Cucu Laura-Elena 39
- Carvajal Réné 45
- Carvajal Réné 46
- Hernandez Hiled Melissa 51
- Zimianiti Ioanna 86
- Damasceno Alfredo 32
- Frederiksen Jette 11
- Koc Emine 53
- Jensen Birgit 71
- Martinet Yves 76
- Kubala Havrdova Eva 84
- Naismith Robert 88
- Selmaj Krzysztof 89
- Seferoğlu Meral 93
- Hobart Jeremy 95
- Hobart Jeremy 96
- Hobart Jeremy 97
- Hobart Jeremy 98
- Delgado Soares Mafalda 3
- Plesa Andreea 7
- Plesa Andreea 9
- Simon Teodora-Ioana 13
- Zhang Tian-Xiang 14
- Huang Xiaoyu 25
- Guan Shuzhen 32
- Delsanti Romain 34
- Carvajal Réné 47
- Aravinthan Mythily 55
- Ciampana Valentina 60
- Pisa Marco 62
- Samadzadeh Sara 77
- Kubala Havrdova Eva 84
- In memory of Prof. Dr. Giancarlo Comi
- Update on NMOSD & MOGAD programme
- Update on NMOSD & MOGAD Meeting 2025 - Onsite Registration
- Update on NMOSD & MOGAD Meeting 2025- Online Registration
- SLCTRIMS 2025 - 6th Annual Congress
- 34th Annual Meeting, November 12-14, 2026, "Treatment Efficacy and Risk Management Across the Disease Course"
- Cony congress, ECF symposium
- Malvaso Antonio 2
- Posters - NMOSD & MOGAD
- Liu Rui 3
- Lessa Leandro 4
- Qi Zhihui 5
- Da Silva Ana Paula Bornes 6
- Rossoni Ronchi Nathalia 7
- Zhang Li-Jie 8
- Zhang Li-Jie 9
- Brandet João Marcos 10
- de Oliveira Trintinalha Mariana 11
- Tavares Francisco 12
- Afzali Ali Maisam 13
- Talim Natália C. 14
- Avila Duarte Juliana 16
- Avila Duarte Juliana 19
- Avila Duarte Juliana 18
- Pelayo Carolina 22
- Pelayo Carolina 24
- Domingues Karina 25
- Canales Diego 26
- Zhang Tian-Xiang 27
- Santos Karlos 29
- Ferraz de Abreu Bruno 30
- Valdés José Miguel 31
- Peixoto Marco Aurélio Lana 33
- Peixoto Marco Aurélio Lana 34
- Peixoto Marco Aurélio Lana 35
- Peixoto Marco Aurélio Lana 36
- Peixoto Marco Aurélio Lana 40
- Braga Nathane 41
- Astara Kyriaki 42
- Pinto Thales 43
- Santillán Thiago 44
- Lacerda Pereira Nobrega Ivna 45
- Araujo Roger 47
- Martinez Lopez Yazmin 50
- Peixoto Marco Aurélio Lana 51
- Pitombeira Milena 52
- Kuroda Hiroshi 53
- Diogo Silva Guilherme 55
- Dias Amanda 57
- Moreira Cardoso Maria Eduarda 59
- Leppert David 1
- Bessa Santiago Igor 60
- Valdés José Miguel 62
- Pedrosa Denison 63
- Tkachuk Veronica 64
- Passos Giordani 65
- Queiroga Rafael 66
- Boldrini Vinicius 67
- Romero César 68
- Tkachuk Veronica 69
- Pimentel Vitória 71
- Souza Larissa 73
- Hor Jyh Yung 74
- Flores Alfaro Fernanda 75
- 'Update on NMOSD and MOGAD' Workshop
- ACTRIMS 2025 - The Annual ACTRIMS Forum 2025
- Mystery Solved Project 2025
- Mystery Solved programme
- LATAM Meeting & Summit LACTRIMS 2025
- MEXTRIMS National Congress 2025
- Joint Pre-ECTRIMS Course 2025
- XXVII World Congress of Neurology (WCN 2025)
- Med-Ex Learning 2025
- World MS day - May 30 2025
- BCTRIMS - 26th Brazilian Meeting on Multiple Sclerosis
- Altered EBV-specific immune control in MS: involved in EBV clearance or in autoimmunity - Christian Münz
- B cell differentiation and EBV infection, role of B cells in lyctic replication - Micah Luftig
- EBV implication in New MS Disease Activity - Simon Thibault
- EBV-infected B cells in the central nervous system - Roberta Magliozzi
- Using Spontaneous Lymphoblastic Cell Lines (SLCLs) to Model Pathogenic EBV-infected B cells in MS - Paul Lieberman
- Isolation and expansion of endogenous EBV-infected B cells for EBV genome analysis - Pentti Tienari
- EBV lyctic replication and MS: clinical trials - Øivind Torkildsen
- Presentation of the Behind-MS EU Consortium and a few suggestions for multicentric preclinical studies on EBV and MS - Henri Jacques Delecluse
- Pathogenic antibodies against EBV proteins - Jan Lünemann
- The anti-EBV TCR repertoire - Tilman Schneider-Hohendorf
- EBV epitope presentation to T cells - Roland Martin
- Mimicry to GlialCAM to anoctamin 2 and to alpha-chrystallin B - Tobias Volker Lanz / Olivia Thomas
- Actors in mimicry control: NK, HLA and CMV - Hannes Vietzen / Paul Rommer
- Antiviral therapies - Gavin Giovannoni
- Anti-EBV vaccines - Jeffrey Cohen
- New therapeutic strategies in early MS / New strategies/perspectives in causal MS research (open discussion)
- Highlights and insights: a recap of the two-day webinar - Patrick Vanderdonckt
- Conclusions day 1 - Hans Lassman
- Opening Mystery Solved Project 2025 - Patrick Vanderdonckt
- Opening day 2 Mystery Solved Project 2025 - Patrick Vanderdonckt
- EBV epitope presentation to T cells - Natalia Drosu
- ICTRIMS 2025
- ECTRIMS 2025
- SIMPOSIO INTERNACIONAL de EM & NMOSD
- 3rd Annual BCTRIMS & ECF Joint Meeting
- ECF Proudly Supports Patient Community Day 2025
- 'Update on NMOSD and MOGAD #2' Workshop
- Update on NMOSD & MOGAD programme
- SLCTRIMS 2026 - 7th Annual Congress
- CLAIMS: Clinical Impact through AI assisted MS Care
- ACTRIMS Forum 2026
- LACTRIMS 2026
- World Congress on Controversies in Neurology (CONy)
- MEXCTRIMS 2026
- BCTRIMS 2026
- Webinars on Progressive MS - supported by Sanofi
- ICTRIMS 2026
- 2026 Joint MS Academia
- 31st Annual RiMS Conference 2026
- Scientific Programme
- Satellite Symposia Programmes
- Poster Viewing Sessions
- Poster Presentations
- Registration Information
- Hotel Reservation
- Young Investigators and ECF Fellows presenting a poster
- Abstract Submission
- Submission criteria
- Why submit an abstract?
- Young Investigator Awards
- Accreditation Info
- 32nd Annual Meeting Scientific Committee
- Young Investigator Award Winners 2023
- Privacy Notice and Terms & Conditions
- #ECF2024 - LinkedIn & X promotional tools
- Joint ACTRIMS-ECTRIMS Meeting 2026, Toronto
- Scientific Programme 2026